New Breast Cancer Cell Lines with HER-2/neu Amplification
Author Information
Author(s): P. Meltzer, A. Leibovitz, W. Dalton, H. Villar, T. Kute, J. Davis, R. Nagle, J. Trent
Primary Institution: University of Michigan Cancer Center
Hypothesis
The study aims to establish and characterize new human breast cancer cell lines with HER-2/neu amplification.
Conclusion
The UACC-812 and UACC-893 cell lines exhibit significant HER-2/neu amplification and may serve as useful models for studying breast cancer.
Supporting Evidence
- Both cell lines are aneuploid and hormone receptor negative.
- UACC-812 and UACC-893 show distinct morphological characteristics consistent with breast carcinoma.
- Both lines exhibit amplification of the HER-2/neu oncogene.
Takeaway
Scientists created two new cell lines from breast cancer samples that have a specific gene change, which could help in understanding and treating breast cancer better.
Methodology
Cell lines UACC-812 and UACC-893 were established from biopsy specimens and characterized for growth properties, hormone receptor status, and genetic features.
Limitations
The establishment of cell lines from breast tissue remains challenging, with only two successful lines out of many attempts.
Participant Demographics
UACC-812 was derived from a 42-year-old woman with Stage IV breast cancer, and UACC-893 from a 57-year-old woman with metastatic disease.
Want to read the original?
Access the complete publication on the publisher's website